Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 54 EP applications Lindsey Claire Woolley has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11748246

INCREASING PLANT GROWTH BY MODULATING OMEGA-AMIDASE EXPRESSION IN PLANTS

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
University of Maine System Board of Trustees
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11769579

ANTI-POLYUBIQUITIN ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11754597

BIOMARKERS AND METHODS OF TREATMENT

IPC classification:
A61K 39/00, G01N 33/574
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP12178200

Prevention of disulfide bond reduction during recombinant production of polypeptides

IPC classification:
C07K 1/00, C07K 14/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP11807376

SQUASH LEAF CURL VIRUS (SLCV) RESISTANCE IN CUCURBITS

IPC classification:
A01H 1/00, A01H 1/04, A01H 5/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13154283

Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 5/12, C12N 15/13
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13165235

Apoptotic anti-IgE antibodies

IPC classification:
A01K 67/027, A61P 37/06, C07K 16/42
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP13183384

Anti-FGFR3 antibodies and methods using same

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12781555

CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES

IPC classification:
A61K 39/395, A61P 35/00, A61P 35/02, C07K 16/28
Applicant:
University of California
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844824

INHIBITION OF COLLAGEN SYNTHESIS

IPC classification:
A61K 38/17, C07K 14/47
Applicant:
University of Manitoba Technology Transfer Office
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12787307

DRUG SCREENING AND POTENCY ASSAYS

IPC classification:
C12N 5/00, G01N 33/50
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13162222

Biochemical analysis of partitioned cells

IPC classification:
C12Q 1/68
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14166919

Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis

IPC classification:
A61K 38/17, C07K 14/47, C07K 14/705, C07K 16/18, C07K 16/28, C12N 15/12, C12N 15/62, C12Q 1/68, G01N 33/53
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11807988

PHYTOPHTHORA RESISTANCE IN SWEET PEPPERS

IPC classification:
A01H 5/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13761535

TOOL AND METHOD FOR REPAIRING TUBULAR MEMBERS

IPC classification:
B24B 19/02, B29C 73/02, B29C 73/30, A63B 59/14
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13716131

ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12822145

ANTI-POLYUBIQUITIN ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13785317

OPEN-ENDED RATCHET WRENCH

IPC classification:
B25B 13/02, B25B 13/08, B25B 13/46
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13721529

ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 47/48, C07K 16/28, C07K 16/30
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13174782

Plant superoxide dismutase expression resistant to micro-RNA regulation

IPC classification:
C12N 5/12, C12N 15/12, C12N 15/52
Applicant:
University of California
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189582

Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

IPC classification:
C07K 1/18, C07K 1/34, C07K 1/36
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13724493

HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/10, A61K 9/16
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11793523

INJECTABLE FORMULATIONS FOR ORGAN AUGMENTATION

IPC classification:
A61L 27/22, A61L 27/38, A61L 27/50, A61L 27/52
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13737118

IMMUNOCONJUGATES COMPRISING ANTI - CD79B ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13739333

IMMUNOCONJUGATES COMPRISING ANTI-CD22 ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13739332

IMMUNOCONJUGATES COMPRISING ANTI-CD79B ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP13739331

IMMUNOCONJUGATES COMPRISING ANTI-CD22 ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Genentech, Inc.
Applicant:
MedImmune Limited
Applicant:
Spirogen Sàrl
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13826433

ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13786132

RENAL CELL POPULATIONS AND USES THEREOF

IPC classification:
C12N 5/071
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13865282

HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF

IPC classification:
A61K 31/496, A61P 35/00, C07D 295/192, C07D 417/14, C07K 17/06
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743859

TISSUE PLASMINOGEN ACTIVATOR ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 38/36, A61P 7/04, C07K 14/75
Applicant:
University of Tennessee Research Foundation
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Agent:
Kerry Linda Verhorevoort, Bridle Intellectual Property Ltd
Status:
GRANT OF PATENT INTENDED
EP14717318

ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14742047

ANTI-FCRH5 ANTIBODIES

IPC classification:
A61K 39/395, A61K 47/48, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The patent has been granted
EP14752733

DELIVERY NEEDLE WITH ELEVATOR/PADDLE FOR MICRONIZED ALLOGRAFT TISSUE

IPC classification:
A61B 17/56
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14752732

MENISCAL PROBE CUTTER

IPC classification:
A61B 17/3207
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14856653

ANTI-Ly6E ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14824269

ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869424

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14828608

ANTI-CD3 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/28, C07K 16/30, C07K 16/32
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP16159976

BISPECIFIC ANTI-HER ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15755175

METHODS AND COMPOSITIONS FOR TREATING SIGLEC-8 ASSOCIATED DISEASES

IPC classification:
A61K 39/395, A61P 37/00
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16185385

COMBINED AUTOLOGOUS BIOLOGIC AND COLD THERAPY TREATMENT OF SKIN INJURIES

IPC classification:
A61F 2/10, A61J 1/14, A61K 35/19, A61L 27/36, F25D 3/08
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP16196757

BIOACTIVE RENAL CELLS

IPC classification:
C12N 5/071, C12N 15/113, C12Q 1/68
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15772090

ANTI-HER2 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/00, C07K 16/32, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15770739

ANTI-CLL-1 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/02, C07K 16/28, C07K 16/30, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15767037

ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
C07K 16/28, C07K 16/30, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15779065

IMMUNOCONJUGATES COMPRISING ANTI-HER2 ANTIBODIES AND PYRROLOBENZODIAZEPINES

IPC classification:
A61P 35/00, A61K 47/50
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17156352

ANTI-CD3 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/28, C07K 16/30, C07K 16/32
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP16205172

EXPRESSION OF SURROGATE LIGHT CHAINS

IPC classification:
C07K 14/705, C12N 15/10
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15797531

METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA

IPC classification:
C07K 16/00, C07K 16/22, C07K 16/24, C07K 16/28, C12N 15/63, C12P 21/00
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP17152167

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

IPC classification:
A61P 37/02, C07K 14/705, C07K 16/28, G01N 33/50, G01N 33/564, G01N 33/569
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
The application has been published
EP15805020

ANTIBODIES AGAINST BACE1 AND USE THEREOF FOR NEURAL DISEASE IMMUNOTHERAPY

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/40
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15804651

ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 25/00, C07K 16/28, C07K 16/40, C07K 16/46, C12N 15/13
Applicant:
Genentech, Inc.
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made
EP15775572

SURGICAL IMPLANT WITH POROUS REGION

IPC classification:
A61B 17/04, A61B 17/80, A61B 17/86, A61F 2/08, A61L 31/14
Applicant:
Arthrex Inc
Agent:
Lindsey Claire Woolley, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature